Quiescence in Active and Inactive Non-Infectious, Intermediate, Posterior, or Panuveitis in Patients Treated with Adalimumab

被引：0
|
作者：
Landewe, Robert [1 ]
van der Horst-Bruinsma, Irene [2 ]
Tari, Samir [3 ]
Florentinus, Stefan [3 ]
Song, Alexandra P. [3 ]
Kron, Martina [4 ]
Pathai, Sophia [5 ]
Roseribaum, James T. [6 ,7 ]
机构：
[1] Univ Amsterdam, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Rheumatol, Amsterdam, Netherlands
[3] AbbVie Inc, N Chicago, IL USA
[4] Abbvie Deutschland GmbH & Co KG, Ludwigshafen, Germany
[5] AbbVie Ltd, Maidenhead, Berks, England
[6] Oregon Hlth & Sci Univ, Casey Eve Inst, Portland, OR 97201 USA
[7] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3077
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Multimodal imaging in infectious and noninfectious intermediate, posterior and panuveitis
    Thomas, Akshay S.
    Lin, Phoebe
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2021, 32 (03) : 169 - 182
  • [32] Adalimumab in the treatment of non-infectious uveitis
    Burek-Michalska, Alicja
    Turno-Krecicka, Anna
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (10): : 1231 - 1236
  • [33] Infographic: adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II)
    Crisostomo, Kei Gabrielle R.
    Crisostomo, Karl Gerard R.
    Azarcon, Corrina P.
    Artiaga, Jose Carlo M.
    [J]. EYE, 2023,
  • [34] Adalimumab treatment in adult patients with refractory non-infectious uveitis
    Esen, Ebru
    Isik, Puren
    Sizmaz, Selcuk
    Demircan, Nihal
    [J]. CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 457 - 462
  • [35] Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis
    Yang, Ming-ming
    Lai, Timothy Y. Y.
    Tam, Pancy O. S.
    Chiang, Sylvia W. Y.
    Chan, Carmen K. M.
    Luk, Fiona O. J.
    Ng, Tsz-Kin
    Pang, Chi-Pui
    [J]. MOLECULAR VISION, 2012, 18 (193-95): : 1865 - 1873
  • [36] COST-EFFECTIVENESS OF ORIGINATOR ADALIMUMAB IN NON-INFECTIOUS INTERMEDIATE, POSTERIOR AND PAN-UVEITIS FROM A SOCIETAL PERSPECTIVE IN PORTUGAL
    Crespo, A. R.
    Farinha, S. A.
    Martins, V
    Marinho, A.
    Godinho, F.
    Figueira, L.
    Proenca, R.
    Nogueira, V
    Botteman, M.
    Ektare, V
    Silva, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S452 - S452
  • [37] Long-term Experience with Anti- Tumor Necrosis Factor-α Therapy in the Treatment of Refractory, Non-infectious Intermediate, Posterior and Panuveitis
    Amer, Radgonde
    Vofo, Brice Nguedia
    Corredores, Jamel
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [38] The effectiveness of adalimumab treatment for non-infectious uveitis
    Hasegawa, Eiichi
    Takeda, Atsunobu
    Yawata, Nobuyo
    Sonoda, Koh-Hei
    [J]. IMMUNOLOGICAL MEDICINE, 2019, 42 (02) : 79 - 83
  • [39] Long-term Experience with Anti-tumor Necrosis factor- α Therapy in the Treatment of Refractory, Non-infectious Intermediate, Posterior, and Panuveitis
    Dieb, Jamel Corredores
    Vofo, Brice
    Amer, Radgonde
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (06) : 932 - 939
  • [40] Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy
    Moll-Udina, Aina
    Miguel Escuder, Lucia
    Hernanz, Ines
    Llorenc, Victor
    Fonollosa, Alex
    Cordero Coma, Miguel
    Sainz de la Maza, Maite
    Espinosa, Gerard
    Gonzalez Guijarro, J. Jacobo
    Lopez Lopez, Fernando
    Alba-Linero, Carmen
    Hernandez, Marisa
    Martinez Costa, Lucia
    Celdran Vivancos, Diego
    Giralt, Lena
    Artaraz, Joseba
    Soler Bartrina, Pablo
    Jodar Marquez, Margarita
    Garcia de Vicuna, Rosario
    Esquinas, Cristina
    Adan, Alfredo
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (7-8) : 1591 - 1598
12345